- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00523263
Dacron vs Dardik for Fem-Pop Bypass (DaDa)
August 30, 2007 updated by: Radboud University Medical Center
Heparin Bonded and Collagen Coated Polyester or Human Umbilical Vein for Femoropopliteal Bypass: a Prospective Randomised Multicentre Trial.
Clinical trial for the comparison of long-term patency of heparin-bonded Dacron and human umbilical vein vascular prostheses in above-knee femoro-popliteal bypass surgery.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nijmegen, Netherlands, 6500 HB
- Radboud UMCN, Dept Vascular Surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
31 years to 89 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 31 to 89
- intermittent claudication
- ABI below 0.8
Exclusion Criteria:
- non elective surgery
- life expectancy below 2 yrs
- contraindication for anticoagulant therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Dacron
Patients receiving polyester above-knee femoro-popliteal bypass
|
femoro-popliteal bypass
|
|
Active Comparator: HUV
patients receiving HUV femoro-popliteal bypass
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Primary and primary-assisted bypass patency
Time Frame: 1 - 5 yrs
|
1 - 5 yrs
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Secondary bypass patency
Time Frame: 1 - 5 yrs
|
1 - 5 yrs
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: J. Adam van der Vliet, MD, PhD, Radboud University Medical Center Nijmegen
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Scharn DM, Oyen WJ, Klemm PL, Verhofstad AA, van der Vliet JA. Thrombogenicity and related biological properties of heparin bonded collagen coated polyester and human umbilical vein prosthetic vascular grafts. J Surg Res. 2006 Aug;134(2):182-9. doi: 10.1016/j.jss.2006.01.025. Epub 2006 Mar 20.
- Scharn DM, Oyen WJ, Klemm PL, Wijnen MH, vanderVliet JA. Assessment of prosthetic vascular graft thrombogenicity using the technetium-99m labeled glycoprotein IIb/IIIa receptor antagonist DMP444 in a dog model. Cardiovasc Surg. 2002 Dec;10(6):566-9. doi: 10.1016/s0967-2109(02)00077-7.
- Dirven M, Scharn DM, Blankensteijn JD, van der Vliet JA. Preservation for future use of the autologous saphenous vein during femoro-popliteal bypass surgery is inexpedient. Eur J Vasc Endovasc Surg. 2008 Oct;36(4):420-3. doi: 10.1016/j.ejvs.2008.06.012.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 1996
Study Completion (Actual)
April 1, 2007
Study Registration Dates
First Submitted
August 30, 2007
First Submitted That Met QC Criteria
August 30, 2007
First Posted (Estimate)
August 31, 2007
Study Record Updates
Last Update Posted (Estimate)
August 31, 2007
Last Update Submitted That Met QC Criteria
August 30, 2007
Last Verified
August 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DaDa-trial
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arterial Occlusive Diseases
-
Ryazan State Medical UniversityRecruitingPeripheral Arterial Occlusive DiseaseRussian Federation
-
B. Braun Melsungen AGActive, not recruitingPeripheral Arterial Occlusive DiseaseGermany
-
Maquet CardiovascularCompletedPeripheral Arterial Occlusive DiseaseUnited States, Germany, Czechia
-
University Hospital Inselspital, BerneWithdrawnPeripheral Arterial Occlusive DiseaseSwitzerland
-
Flanders Medical Research ProgramAngioScore, Inc.CompletedPeripheral Arterial Occlusive DiseaseBelgium, Germany
-
OrbusNeichEucatech AG; Centre Européen de Recherche CardiovasculaireRecruitingPeripheral Arterial Disease | Peripheral Arterial Occlusive DiseaseSpain, Singapore, Belgium, Germany
-
Meshalkin Research Institute of Pathology of CirculationCompletedARTERIAL OCCLUSIVE DISEASERussian Federation
-
Hull University Teaching Hospitals NHS TrustWithdrawnPeripheral Arterial Occlusive DiseaseUnited Kingdom
-
Yonsei UniversityCompletedPeripheral Arterial Occlusive DiseaseKorea, Republic of
-
W.L.Gore & AssociatesTerminatedPeripheral Arterial Occlusive DiseaseUnited States
Clinical Trials on heparin-bonded and collagen coated polyster
-
IntervascularRecruitingCarotid Artery Diseases | Aortic Diseases | Peripheral Arterial DiseasesUnited States, Spain, France
-
W.L.Gore & AssociatesTerminatedEnd Stage Renal DiseaseUnited States
-
Rijnstate HospitalCompleted
-
The University of Texas Health Science Center,...University Hospitals Cleveland Medical Center; University of Arkansas; Ochsner...TerminatedEnd-stage Renal DiseaseUnited States
-
Medical University of LodzBaxter Healthcare CorporationUnknownCHD - Coronary Heart DiseasePoland
-
Fundación Pública Andaluza para la gestión de la...Unknown
-
University Hospital, AngersCompletedCoronary Artery Bypass Grafting
-
Oslo University HospitalCompletedRenal FailureNorway
-
Stanford UniversityTerminatedVenous ThrombosisUnited States
-
Hôpital Necker-Enfants MaladesBambino Gesù Hospital and Research InstituteTerminatedAcquired Platelet Function DisorderFrance